Compulsory Licenses Sought

May 2007 | Trade Alert

As a sign of strength in its Free Trade Agreement (FTA) negotiations with the US, Malaysia has clearly stated that it is seeking the right to issue compulsory licenses on patented drugs. It is BMI's view that while Malaysia will be allowed to do this, as permitted by World Trade Organization (WTO) rules, the country will be strongly discouraged to do so by the US, as the profits of multinational drugmakers will be negatively impacted. Moreover, we believe that Malaysia's approach could in fact derail the FTA, given that country is already unwilling to compromise on other issues, such as

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.